PHISO-SCRUB
LOE ApproachingNDATOPICALSPONGE
Approved
Aug 1977
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 3h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PHISO-SCRUB is a topical small-molecule sponge formulation approved in 1977 for dermatological cleansing or antiseptic purposes. The exact mechanism of action and indications are not publicly detailed in available data. This legacy product represents a mature, established category in topical care.
LOE Approaching
Moderate competitive pressure (30/100) suggests niche positioning; expect lean team structure focused on defending market share as exclusivity erodes.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
PHISO-SCRUB currently shows zero linked job openings, reflecting its mature lifecycle stage and small organizational footprint at Sanofi. Working on this product offers exposure to lifecycle management, competitive defense, and cost optimization—valuable for mid-career professionals seeking stability over growth opportunities.
Brand ManagerProduct Manager
Worked on PHISO-SCRUB at Sanofi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.